Plasma Proteomics for Epidemiology: Increasing Throughput With Standard-Flow Rates
暂无分享,去创建一个
Lukas Reiter | Manuel Mayr | Raimund Pechlaner | Johann Willeit | Tejas Gandhi | Tejas Gandhi | L. Reiter | Xiaoke Yin | M. Mayr | S. Kiechl | J. Willeit | J. Witztum | P. Santer | S. Tsimikas | Xiaoke Yin | Joseph L Witztum | Sotirios Tsimikas | Ferheen Baig | Stefan Kiechl | Sebastian Müller | Eloi Haudebourg | Richard T Blankley | Sebastian Müller | Helmut Hinterwirth | Peter Santer | Anthony Sullivan | Richard T. Blankley | R. Pechlaner | Eloi Haudebourg | Anthony. G. Sullivan | H. Hinterwirth | Ferheen Baig | X. Yin | F. Baig
[1] C. Borchers,et al. Multiple Reaction Monitoring (MRM): Principles and Application to Coronary Artery Disease , 2012, Circulation. Cardiovascular genetics.
[2] Ildikó V. Tóth,et al. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels , 2017, Nature Medicine.
[3] Douglas G. Altman,et al. Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .
[4] Steven W. Taylor,et al. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory. , 2013, Clinical chemistry.
[5] S. Grebe,et al. LC-MS/MS in the Clinical Laboratory - Where to From Here? , 2011, The Clinical biochemist. Reviews.
[6] Susan E. Abbatiello,et al. Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach* , 2014, Molecular & Cellular Proteomics.
[7] Michael J. Walker,et al. A Label-free Selected Reaction Monitoring Workflow Identifies a Subset of Pregnancy Specific Glycoproteins as Potential Predictive Markers of Early-onset Pre-eclampsia* , 2013, Molecular & Cellular Proteomics.
[8] Ruedi Aebersold,et al. Quantitative variability of 342 plasma proteins in a human twin population , 2015 .
[9] N. Anderson,et al. A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.
[10] G. Jarvik,et al. Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics. , 2015, Journal of proteomics.
[11] Bruno Domon,et al. Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.
[12] F. Kronenberg,et al. Lipoprotein(a): resurrected by genetics , 2013, Journal of internal medicine.
[13] T. Pearson,et al. High precision quantification of human plasma proteins using the automated SISCAPA Immuno-MS workflow. , 2016, New biotechnology.
[14] C. Borchers,et al. Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins , 2012, Analytical and Bioanalytical Chemistry.
[15] N. Rifai,et al. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). , 2000, Clinical chemistry.
[16] T. Spector,et al. Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study , 2014, Circulation.
[17] Jeffrey R. Whiteaker,et al. Sequential Multiplexed Analyte Quantification Using Peptide Immunoaffinity Enrichment Coupled to Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[18] Andreas Stengel,et al. The importance of using the optimal plasticware and glassware in studies involving peptides. , 2011, Analytical biochemistry.
[19] Xiaoke Yin,et al. Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III , 2017, Journal of the American College of Cardiology.
[20] Leigh Anderson. Six decades searching for meaning in the proteome. , 2014, Journal of proteomics.
[21] L. Holdt,et al. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study , 2014, Critical Care.
[22] S. Carr,et al. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.
[23] G. Nicol,et al. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. , 2005, Journal of proteome research.
[24] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[25] Leigh Anderson,et al. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.
[26] Juncong Yang,et al. MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.
[27] N. Anderson,et al. The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.
[28] Darryl B. Hardie,et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.
[29] Zeneng Wang,et al. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk , 2013 .
[30] Matthias Mann,et al. Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.
[31] Amanda G. Paulovich,et al. An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.
[32] J. Garin,et al. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics. , 2011, Methods in molecular biology.
[33] T. Pearson,et al. Multiplexed longitudinal measurement of protein biomarkers in DBS using an automated SISCAPA workflow. , 2016, Bioanalysis.
[34] T. Annesley. Ion suppression in mass spectrometry. , 2003, Clinical chemistry.
[35] Chris Sander,et al. Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome , 2016, Cell.
[36] Ruedi Aebersold,et al. Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics , 2012, Science Translational Medicine.
[37] N. Spooner,et al. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. , 2001, Analytical chemistry.